Cargando…
Social and medical needs of rare metabolic patients: results from a MetabERN survey
BACKGROUND: Many surveys have been performed over the years to assess the medical and social requirements of patients with a rare disease, but no studies have focused specifically on patients in Europe or with an inherited metabolic disease (IMD). To obtain a comprehensive overview of the social and...
Autores principales: | Sestini, Sylvia, Paneghetti, Laura, Lampe, Christina, Betti, Gianni, Bond, Simon, Bellettato, Cinzia Maria, Maurizio, Scarpa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329639/ https://www.ncbi.nlm.nih.gov/pubmed/34344397 http://dx.doi.org/10.1186/s13023-021-01948-5 |
Ejemplares similares
-
The impact of COVID-19 on rare metabolic patients and healthcare providers: results from two MetabERN surveys
por: Lampe, C., et al.
Publicado: (2020) -
Research activity and capability in the European reference network MetabERN
por: Heard, Jean-Michel, et al.
Publicado: (2019) -
One year of COVID-19: infection rates and symptoms in patients with inherited metabolic diseases followed by MetabERN
por: Paneghetti, Laura, et al.
Publicado: (2022) -
Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network
por: Heard, Jean-Michel, et al.
Publicado: (2020) -
Challenges in Transition From Childhood to Adulthood Care in Rare Metabolic Diseases: Results From the First Multi-Center European Survey
por: Stepien, Karolina M., et al.
Publicado: (2021)